A two-tiered high-flow nasal cannula approach does not increase intensive care utilization and hospital length of stay in bronchiolitis

Author:

Tirelli Francesca,Todeschini Premuda Marco,Francaviglia Giulia,Frigo Anna Chiara,Baraldi Eugenio,Da Dalt Liviana,Bressan Silvia

Abstract

AbstractWhile concerns about high-flow nasal cannula oxygen (HFNC) overuse and associated increased use of hospital resources are rapidly spreading, a two-tiered approach in its use is recommended by recent bronchiolitis guidelines. However, data on its effects in practice have not been reported. We aimed to analyze the trends in use of HFNC, hospitalizations, length of stay (LOS), and intensive care unit (ICU) admissions for bronchiolitis in a tertiary care center using a two-tiered HFNC approach since its introduction in practice. We retrospectively included data of children < 12 months of age who presented to the Paediatric Emergency Department (PED) and were hospitalized for bronchiolitis at our institution in the epidemic season between October 1st and April 30th during the years 2012–2023 and compared the clinical data across the years. Of the 687 hospitalized children included, 79.9% required oxygen supplementation. Use of HFNC significantly increased since its implementation (from 25% in 2012–2013 to over 60% since 2019–2020, p < 0.0001) and was most frequently administered as rescue treatment (in 57.5% of patients). There was no increased trend in ICU admissions (between 1.5% and 10.0% of hospitalizations across seasons, p = 0.40), while LOS, after increasing between 2013 and 2016 (medians between 4.0 and 5.4 days), remained stable thereafter (medians between 3.8 and 4.3 days).Conclusions: The use of HFNC according to a two-tiered approach does not appear to be associated with an increase in ICU utilization or LOS. What is Known:Bronchiolitis is one of the most common reasons for hospitalization in infants.• Use high-flow nasal canulae oxygen (HFNC) has rapidly spread outside the intensive care unit (ICU) to treat infants with bronchiolitis, although increasing evidence has dampened the initial enthusiasm about their effectiveness.Concerns nowadays are rising about HFNC overuse and associated increased use of hospital resources, including escalation of care to ICU. What is New: A more selective use of HFNC according to a “two-tiered approach”, intended as a second-line rescue treatment in non-severely ill children who fail standard oxygen therapy, is not associated with increased ICU and length of hospital stay.

Funder

Università degli Studi di Padova

Publisher

Springer Science and Business Media LLC

Reference12 articles.

1. Ghirardo S, Ullmann N, Ciofi Degli Atti ML, Raponi M, Cutrera R (2021) Delayed season’s onset and reduction of incidence of bronchiolitis during COVID-19 pandemic. Pediatr Pulmonol. 56(8):2780–2781. https://doi.org/10.1002/ppul.25461

2. Indolfi G, Resti M, Zanobini A (2022) Associazione Ospedali Pediatrici Italiani Research Group on Bronchiolitis. Outbreak of Respiratory Syncytial Virus Bronchiolitis in Italy. Clin Infect Dis 75(3):549-550. https://doi.org/10.1093/cid/ciac120. Erratum in: Clin Infect Dis. 2023 Feb 18;76(4):777-779

3. Faraguna MC, Lepri I, Clavenna A, Bonati M, Vimercati C, Sala D, Cattoni A, Melzi ML, Biondi A (2023) The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy. Ital J Pediatr 49(1):26. https://doi.org/10.1186/s13052-023-01425-8

4. O'Brien S, Craig S, Babl FE, Borland ML, Oakley E, Dalziel SR (2019) Paediatric Research in Emergency Departments International Collaborative (PREDICT) Network, Australasia. 'Rational use of high-flow therapy in infants with bronchiolitis. What do the latest trials tell us?' A Paediatric Research in Emergency Departments International Collaborative perspective. J Paediatr Child Health 55(7):746–752. https://doi.org/10.1111/jpc.14496

5. Franklin D, Babl FE, George S, Oakley E, Borland ML et al (2023) Effect of early high-flow nasal oxygen vs standard oxygen therapy on length of hospital stay in hospitalized children with acute hypoxemic respiratory failure: the PARIS-2 randomized clinical trial. JAMA 329(3):224-234. https://doi.org/10.1001/jama.2022.21805. Erratum in: JAMA. 2023 Apr 11;329(14):1226

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3